Nektar Therapeutics
NKTRNasdaqCIK 906709HealthcareFiscal year ends Dec 31
Reports and events: 341 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0111:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-105453 |
| 2026-09-2511:00 ET | 8-K | 8.01 Other events | 0001213900-26-103215 |
| 2026-09-0820:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098042 |
| 2026-08-1422:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349805 |
| 2026-08-1320:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-089137 |
| 2026-06-0520:30 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-065845 |
| 2026-05-0821:11 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-214976 |
| 2026-05-0822:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212596 |
| 2026-05-0720:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-053369 |
| 2026-04-2420:15 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001140361-26-016708 |
| 2026-04-2310:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-171731 |
| 2026-04-2020:58 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-164186 |
| 2026-04-2012:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-162763 |
| 2026-03-1322:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104547 |
| 2026-03-1220:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-027026 |
| 2026-02-1301:23 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-049378 |
| 2026-02-1021:21 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-044751 |
| 2026-02-1013:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-043755 |
| 2026-01-2721:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008210 |
| 2025-12-1613:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-320009 |
| 2025-11-2121:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-113606 |
| 2025-11-1011:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-107821 |
| 2025-11-0722:58 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-270230 |
| 2025-11-0621:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107180 |
| 2025-09-1812:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-088792 |
| 2025-08-0821:59 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105275 |
| 2025-08-0720:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-073100 |
| 2025-07-0120:44 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-154062 |
| 2025-06-2721:15 ET | 8-K | 8.01 Other events | 0001213900-25-059115 |
| 2025-06-2411:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056909 |
| 2025-06-0620:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-052141 |
| 2025-06-0420:30 ET | 8-K | 8.01 Other events | 0001213900-25-051191 |
| 2025-05-2822:27 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-047890 |
| 2025-05-0922:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067279 |
| 2025-05-0820:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-041085 |
| 2025-04-2520:15 ET | DEF 14A | Proxy statementPeriod 2025-05-23 | 0001140361-25-015744 |
| 2025-04-0420:05 ET | 8-K | 3.01 Delisting notice | 0001213900-25-029002 |
| 2025-03-2821:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001013762-25-004236 |
| 2025-03-1420:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-039389 |
| 2025-03-1220:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-023220 |
| 2025-02-2412:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-016278 |
| 2025-02-0421:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010085 |
| 2024-12-0214:24 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-24-104240 |
| 2024-11-0822:59 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123570 |
| 2024-11-0721:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-095423 |
| 2024-11-0413:52 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-093768 |
| 2024-08-0921:51 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094231 |
| 2024-08-0820:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-066630 |
| 2024-06-0620:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-050365 |
| 2024-05-1022:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057312 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.